Neisseria meningitidis is a Gram-negative β-proteobacterium responsible for an endemic worldwide infection. The epidemiology and serogroup distribution can change very quickly. The incidence of meningitis infection varies from very rare to more than 1000 cases per 100,000 of the population yearly. The carriage of N. meningitidis, which represents an exclusive human commensal, is asymptomatic, but in rare cases bacteria proliferate in the CNS and rapidly lead to the death of the affected subjects. Host genetic factors, such as single nucleotide polymorphisms, can promote meningococcal disease, being able to influence the individual predisposition to the pathology. Although a reduction in meningococcal disease has been observed in Europe, a continuous surveillance is necessary to control any possible outbreaks of new hypervirulent clones into populations that could modify the epidemiology of meningococcal infections and the clinical spectrum of affected subjects.

Gianchecchi, E., Torelli, A., Piccini, G., Piccirella, S., Montomoli, E. (2015). Neisseria meningitidis infection: Who, when and where?. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 13(10), 1249-1263 [10.1586/14787210.2015.1070096].

Neisseria meningitidis infection: Who, when and where?

GIANCHECCHI, ELENA;TORELLI, ALESSANDRO;PICCINI, GIULIA;PICCIRELLA, SIMONA;MONTOMOLI, EMANUELE
2015-01-01

Abstract

Neisseria meningitidis is a Gram-negative β-proteobacterium responsible for an endemic worldwide infection. The epidemiology and serogroup distribution can change very quickly. The incidence of meningitis infection varies from very rare to more than 1000 cases per 100,000 of the population yearly. The carriage of N. meningitidis, which represents an exclusive human commensal, is asymptomatic, but in rare cases bacteria proliferate in the CNS and rapidly lead to the death of the affected subjects. Host genetic factors, such as single nucleotide polymorphisms, can promote meningococcal disease, being able to influence the individual predisposition to the pathology. Although a reduction in meningococcal disease has been observed in Europe, a continuous surveillance is necessary to control any possible outbreaks of new hypervirulent clones into populations that could modify the epidemiology of meningococcal infections and the clinical spectrum of affected subjects.
2015
Gianchecchi, E., Torelli, A., Piccini, G., Piccirella, S., Montomoli, E. (2015). Neisseria meningitidis infection: Who, when and where?. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 13(10), 1249-1263 [10.1586/14787210.2015.1070096].
File in questo prodotto:
File Dimensione Formato  
057_2016_ExpRAIT-Gianchecchi.pdf

non disponibili

Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 719.38 kB
Formato Adobe PDF
719.38 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1008652
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo